Literature DB >> 6975975

T-cell subset analysis by monoclonal antibodies in primary immunodeficiencies.

F Phan-Dinh-Tuy, A Durandy, C Griscelli, M A Bach.   

Abstract

T-cell subsets have been analysed in 23 cases of primary immunodeficiency with monoclonal antibodies. Functional assays investigating T-cell function--proliferative response to mitogens, antigens, and allogeneic cells, cytotoxicity generated against allogeneic target cells and helper function to pokeweek mitogen-induced immunoglobulin synthesis--were performed in parallel in the same patients. The results enabled us to delineate four groups of patients. The first group consisted of patients in whom marker and function studies show concordant data, with either normal or strongly decreased T-cell number and function. The second group consisted of patients in whom various degrees of functional abnormality coexist with subnormal T-cell number and increased suppressor T-cell proportion. In the third group, we collected all patients who showed functional deficiencies without marker abnormalities. Finally, there was a small group composed of patients whose T-cell pattern was strongly suggestive of abnormal differentiation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975975     DOI: 10.1111/j.1365-3083.1981.tb00199.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin.

Authors:  H Shiratsuchi; I Tsuyuguchi
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

2.  Lymphocyte subpopulations in primary immunodeficiency disorders.

Authors:  E G Davies; R J Levinsky; M Butler; R M Thomas; D C Linch
Journal:  Arch Dis Child       Date:  1983-05       Impact factor: 3.791

3.  Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes.

Authors:  A Durandy; A Fischer; C Griscelli
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.